1,617
Participants
Start Date
November 1, 2017
Primary Completion Date
July 31, 2019
Study Completion Date
August 27, 2019
Inclisiran Sodium
Inclisiran is a small interfering ribonucleic acid (RNA) that inhibits PCSK9 synthesis.
Placebo
Placebo will be supplied as sterile normal saline (0.9% sodium chloride in water for injection).
Research Site 11027-006, Pretoria
Research Site 11036-001, Budapest
Research Site 11027-005, Johannesburg
Research Site - 11380-001, Kyiv
Research Site 11036-002, Hatvan
Research Site - 11380-002, Kyiv
Research Site - 11380-003, Kyiv
Research Site - 11380-004, Kiev
Research Site - 11380-009, Kiev
Research Site 11036-004, Debrecen
Research Site 11049-001, Leipzig
Research Site 11027-007, Kuils River
Research Site 11027-004, Somerset West
Research Site 11027-001, Cape Town
Research Site 11027-013, Cape Town
Research Site - 11380-006, Uzhhorod
Research Site 11036-003, Zalaegerszeg
Research Site 11027-003, Bloemfontein
Research Site 11027-011, Welkom
Research Site 11049-006, Berlin
Research Site - 11380-005, Cherkasy
Research Site 11420-002, Chomutov
Research Site 11049-002, Bochum
Research Site 11049-003, Frankfurt
Research Site - 11380-008, Kharkiv
Research Site 11420-003, Uherské Hradiště
Research Site 11049-007, Heidelberg
Research Site - 11380-007, Lviv
Research Site 11048-018, Bydgoszcz
Research Site 11048-016, Brzozów
Research Site 11048-019, Ruda Śląska
Research Site 11048-011, Bydgoszcz
Research Site 11048-004, Gdansk
Research Site 11048-017, Gdansk
Research Site 11048-005, Gdynia
Research Site 11048-007, Katowice
Research Site 11048-012, Katowice
Research Site 11048-014, Krakow
Research Site 11048-003, Krakow
Research Site 11048-008, Lublin
Research Site 11048-001, Poznan
Research Site 11048-013, Rzeszów
Research Site 11048-015, Tarnów
Research Site 11048-009, Warsaw
Research Site 11048-006, Warszawice
Research Site 11048-002, Wroclaw
Research Site 11048-010, Wroclaw
Research Site - 11044-006, Edgbaston
Research Site - 11044-022, Sale
Research Site - 11044-023, Sale
Research Site - 11044-021, Timperley
Research Site - 11044-012, Liskeard
Research Site - 11044-009, Exeter
Research Site - 11044-019, Plymouth
Research Site - 11044-014, Chorley
Research Site - 11044-004, Waterloo
Research Site - 11044-027, Davyhulme
Research Site - 11044-028, Bollington
Research Site - 11044-026, Bury
Research Site - 11044-007, Cardiff
Research Site - 11044-024, Cheadle Hulme
Research Site - 11044-010, Derby
Research Site - 11044-001, Glasgow
Research Site - 11044-008, Hexham
Research Site - 11044-020, Macclesfield
Research Site - 11044-025, Manchester
Research Site - 11044-005, Manchester
Research Site - 11044-029, Manchester
Research Site - 11044-003, Reading
Research Site - 11044-002, Stockton
Lead Sponsor
The Medicines Company
INDUSTRY